These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Investigations of the marine flora and fauna of the Islands of Palau. John Faulkner D; Newman DJ; Cragg GM Nat Prod Rep; 2004 Feb; 21(1):50-76. PubMed ID: 15039835 [TBL] [Abstract][Full Text] [Related]
27. Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mayer AM; Rodríguez AD; Taglialatela-Scafati O; Fusetani N Mar Drugs; 2013 Jul; 11(7):2510-73. PubMed ID: 23880931 [TBL] [Abstract][Full Text] [Related]
28. Screening microbial metabolites for new drugs--theoretical and practical issues. Yarbrough GG; Taylor DP; Rowlands RT; Crawford MS; Lasure LL J Antibiot (Tokyo); 1993 Apr; 46(4):535-44. PubMed ID: 8500997 [No Abstract] [Full Text] [Related]
29. [Advance in researches of drugs derived from marine bacteria]. Lin BX; Huang ZQ; Xie LH Wei Sheng Wu Xue Bao; 2005 Aug; 45(4):657-60. PubMed ID: 16245893 [TBL] [Abstract][Full Text] [Related]
30. Fungal Naphthalenones; Promising Metabolites for Drug Discovery: Structures, Biosynthesis, Sources, and Pharmacological Potential. Ibrahim SRM; Fadil SA; Fadil HA; Eshmawi BA; Mohamed SGA; Mohamed GA Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202181 [TBL] [Abstract][Full Text] [Related]
32. Secondary metabolites from marine microorganisms. Kelecom A An Acad Bras Cienc; 2002 Mar; 74(1):151-70. PubMed ID: 11960184 [TBL] [Abstract][Full Text] [Related]
33. A new era of exploitation of microbial metabolites. Demain AL Biochem Soc Symp; 1983; 48():117-32. PubMed ID: 6400479 [TBL] [Abstract][Full Text] [Related]
34. Integrated approach to explore the potential of marine microorganisms for the production of bioactive metabolites. Wagner-Döbler I; Beil W; Lang S; Meiners M; Laatsch H Adv Biochem Eng Biotechnol; 2002; 74():207-38. PubMed ID: 11991180 [TBL] [Abstract][Full Text] [Related]
35. Cyclic Dipeptides: Secondary Metabolites Isolated from Different Microorganisms with Diverse Biological Activities. Ortiz A; Sansinenea E Curr Med Chem; 2017; 24(25):2773-2780. PubMed ID: 28641557 [TBL] [Abstract][Full Text] [Related]
36. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Zhong JJ; Xiao JH Adv Biochem Eng Biotechnol; 2009; 113():79-150. PubMed ID: 19475376 [TBL] [Abstract][Full Text] [Related]
37. New peptaibols from Mycogone cervina. Wilhelm C; Anke H; Flores Y; Sterner O J Nat Prod; 2004 Mar; 67(3):466-8. PubMed ID: 15043434 [TBL] [Abstract][Full Text] [Related]
38. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Bertrand S; Bohni N; Schnee S; Schumpp O; Gindro K; Wolfender JL Biotechnol Adv; 2014 Nov; 32(6):1180-204. PubMed ID: 24651031 [TBL] [Abstract][Full Text] [Related]
39. Labdanes of natural origin-biological activities (1981-2004). Chinou I Curr Med Chem; 2005; 12(11):1295-317. PubMed ID: 15974998 [TBL] [Abstract][Full Text] [Related]
40. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Villa FA; Gerwick L Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):228-37. PubMed ID: 20441539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]